Author:
Aimono Yuka,Ohkawara Atsushi,Ogawa Tatsunori,Yagisawa Takahiro,Tamura Akihiro
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Appropriate use guide. (2023). https.//www.ono-oncology.jp/sites/default/files/2024-02/mektovi-rmp.pdf.
2. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: an early post-marketing phase vigilance study;Sakata H;Int J Clin Oncol,2023
3. A method for estimating the probability of adverse drug reactions;Naranjo CA;Clin Pharmacol Ther,1981
4. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer;Sharma V;N Engl J Med,2020
5. Treatment manual for each serious side effect of disease. drug-induced liver injury. (2008). Accessed: April 20, 2024: https://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1i01.pdf.